[Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
Main Menu
Home::
Journal Information::
Indexing Sources::
Editorial Board::
Executive Members::
Articles Archive::
Instruction to Authors::
Peer-Review::
Contact Us::
Site Facilities::
::
Search in website

Advanced Search
Receive site information
Enter your Email in the following box to receive the site news and information.
:: Volume 14, Issue 2 (6-2012) ::
J Gorgan Univ Med Sci 2012, 14(2): 48-51 Back to browse issues page
Comparison of protective antibody level against hepatitis B in accelerated and conventional vaccination
Vaziri S (MD) * 1, Khanahmadi A (MD)2 , Najafi F (MD)3 , Khazaei S (MSc)4
1- Associate Professor, Department of Infectious Diseases, Molecular Pathology Research Center, Imam Reza Hospital, Kermanshah University of Medical Sciences, Kermanshah, Iran , vaziri15@yahoo.com
2- General Physician, Molecular Pathology Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran
3- Assistant Professor, Department of Epidemiology, Kermanshah University of Medical Sciences, Kermanshah, Iran
4- MSc in Microbiology, Molecular Pathology Research Center, Imam Reza Hospital Kermanshah, University of Medical Sciences, Kermanshah, Iran
Abstract:   (14461 Views)
Background and Objective: The vaccination against hepatitis B is a front line defence for all at-risk groups. Conventional methods of hepatitis B vaccination (0, 1 and 6 months) is considered a long process. But vaccination at shorter intervals (0, 10 and 21 days) is suggested to achieve rapid immunity. This study was carried out to compare for the protective antibody level against hepatitis B in accelerated and conventional vaccination. Materials and Methods: In this descriptive and analytical study 160 health personnel of Imam Reza hospital of Kermanshah, Iran with no history of vaccination against hepatitis B were selected and divided into two groups during 2009. The volunteers were received vaccination according to accelerated (0, 10 and 21 days) and convetional (0, 1 and 6 months) methods. The antibody titer measured two years after the final dose of vaccination. The acceptable level of antibody was considered higher than 10 IU/ml. Results: After two years the acceptable level of antibody was observed in 94.5% and 97.9% of subjects in accelarated and conventional methods, respectivley. This difference was not significant. Conclusion: This study showed that there is not significant differences between accelerated and conventional methods in antibody production against hepatitis B antigen.
Keywords: Hepatitis B, Vaccination, Accelerated Vaccination, Conventional vaccination
Full-Text [PDF 227 kb] [English Abstract]   (13206 Downloads)    
Type of Study: Original Articles | Subject: Infectious Medicine
Send email to the article author


XML   Persian Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Vaziri S (MD), Khanahmadi A (MD), Najafi F (MD), Khazaei S (MSc). Comparison of protective antibody level against hepatitis B in accelerated and conventional vaccination. J Gorgan Univ Med Sci 2012; 14 (2) :48-51
URL: http://goums.ac.ir/journal/article-1-1321-en.html


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 14, Issue 2 (6-2012) Back to browse issues page
مجله دانشگاه علوم پزشکی گرگان Journal of Gorgan University of Medical Sciences
Persian site map - English site map - Created in 0.04 seconds with 36 queries by YEKTAWEB 4645